Trinh XB - Search Results

1

The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer.

Trinh XB, Tjalma WA, Vermeulen PB, Van den Eynden G, Van der Auwera I, Van Laere SJ, Helleman J, Berns EM, Dirix LY, van Dam PA. Trinh XB, et al. Br J Cancer. 2009 Mar 24;100(6):971-8. doi: 10.1038/sj.bjc.6604921. Epub 2009 Feb 24. Br J Cancer. 2009. PMID: 19240722 Free PMC article.

2

Treatment policy of neuroendocrine small cell cancer of the cervix.

Trinh XB, Bogers JJ, Van Marck EA, Tjalma WA. Trinh XB, et al. Eur J Gynaecol Oncol. 2004;25(1):40-4. Eur J Gynaecol Oncol. 2004. PMID: 15053060 Review.

3

Use of the levonorgestrel-releasing intrauterine system and breast cancer.

Tjalma WA, Trinh XB, van Dam PA. Tjalma WA, et al. Among authors: trinh xb. Obstet Gynecol. 2006 Jan;107(1):207-8; author reply 208. doi: 10.1097/01.AOG.0000195269.76793.bb. Obstet Gynecol. 2006. PMID: 16394064 No abstract available.

4

Plasma concentrations of levonorgestrel in patients with an intrauterine progestogen delivery system: do they have any significance?

Trinh XB, van Dam PA, Tjalma WA. Trinh XB, et al. Maturitas. 2006 Aug 20;55(1):94-5; author reply 96-7. doi: 10.1016/j.maturitas.2006.03.010. Epub 2006 May 3. Maturitas. 2006. PMID: 16675171 No abstract available.

5

Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.

Van den Eynden GG, Van der Auwera I, Van Laere SJ, Trinh XB, Colpaert CG, van Dam P, Dirix LY, Vermeulen PB, Van Marck EA. Van den Eynden GG, et al. Among authors: trinh xb. J Pathol. 2007 Sep;213(1):56-64. doi: 10.1002/path.2211. J Pathol. 2007. PMID: 17674348

6

Use of the levonorgestrel-releasing intrauterine system in breast cancer patients.

Trinh XB, Tjalma WA, Makar AP, Buytaert G, Weyler J, van Dam PA. Trinh XB, et al. Fertil Steril. 2008 Jul;90(1):17-22. doi: 10.1016/j.fertnstert.2007.05.033. Epub 2007 Aug 13. Fertil Steril. 2008. PMID: 17706209 Free article.

7

Relapse-free survival in breast cancer patients is associated with a gene expression signature characteristic for inflammatory breast cancer.

Van Laere S, Beissbarth T, Van der Auwera I, Van den Eynden G, Trinh XB, Elst H, Van Hummelen P, van Dam P, Van Marck E, Vermeulen P, Dirix L. Van Laere S, et al. Among authors: trinh xb. Clin Cancer Res. 2008 Nov 15;14(22):7452-60. doi: 10.1158/1078-0432.CCR-08-1077. Clin Cancer Res. 2008. PMID: 19010862

8

Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.

Van den Eynden GG, Van Laere SJ, Van der Auwera I, Trinh XB, Van Marck EA, Dirix LY, Vermeulen PB. Van den Eynden GG, et al. Among authors: trinh xb. Int J Cancer. 2009 Sep 15;125(6):1494-6. doi: 10.1002/ijc.24524. Int J Cancer. 2009. PMID: 19536843 No abstract available.

9

Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes.

Van der Auwera I, Bovie C, Svensson C, Limame R, Trinh XB, van Dam P, Van Laere SJ, Van Marck E, Vermeulen PB, Dirix LY. Van der Auwera I, et al. Among authors: trinh xb. Cancer Biol Ther. 2009 Dec;8(23):2252-9. doi: 10.4161/cbt.8.23.10133. Epub 2009 Dec 19. Cancer Biol Ther. 2009. PMID: 19829046 Free article.

10

The rationale for mTOR inhibition in epithelial ovarian cancer.

Trinh XB, van Dam PA, Dirix LY, Vermeulen PB, Tjalma WA. Trinh XB, et al. Expert Opin Investig Drugs. 2009 Dec;18(12):1885-91. doi: 10.1517/13543780903321508. Expert Opin Investig Drugs. 2009. PMID: 19888868 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters